We have yet another “teaser” ahead of an extension vote, folks. Forum Merger II Corp. (FMCI), announced tonight, as part of dropping their extension proxy, that they have signed a letter of intent with “a high-growth, plant-based food company with a broad portfolio of innovative products that are aligned with major food trends and sold through leading retailers and distributors across the United States.” It ain’t Beyond Meat (BYND), that’s already public, but….how about Impossible Foods? Which makes the Impossible Burger. We don’t know, but this teaser certainly sounds interesting.
The problem with teasers is, if it’s not something like Impossible Foods, investors will be disappointed. You can’t tease and not deliver. But…if it is something like Impossible Foods? Wow….
We don’t have anything else to go on just yet, but Forum Merger II Corp. intends to hold their extension vote on June 8, 2020. Most likely, once Forum is past the vote (and the trust holds) we could get a definitive announcement shortly thereafter. Perhaps earlier, but if you’re a target company, you’d probably rather wait and see how much cash is left, post-vote, before you sign anything.
Stay tuned…
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...